Novium

📍 St. Augustine, United States🗓 Founded 2014👥 5 employees💰 Last funded Feb 2021
Novium is a pre-clinical stage biopharmaceutical company that is focused on life changing medicinal cannabis formulations coupled with innovative drug delivery systems. We specialize in developing novel, proprietary compounded therapies derived through extensive pharmacology of cannabinoids. Our therapies are focused on specific and targeted terpenoid formulations. These formulations and compounds have been created through 4 decades of research from countries all over the world. Novium’s mission is to significantly improve the lives of millions of patients through delivery of its functional plant based formulations and put them on a “Path to a Better Life”. We are on a mission to ensure that we bring the highest quality products to market that will be consistent and empower consumers to live their best lives!
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2014
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Novium?
Novium has 2 investors on record on gritt.io and 2 late-stage investors.
When did Novium last raise funding?
The most recent investment in Novium recorded on gritt.io was in February 2021.
When was Novium founded?
Novium was founded in 2014.
What industry is Novium in?
Novium operates in Health, Wellness & Fitness. Find similar Health, Wellness & Fitness investors on gritt.io.
Where is Novium based?
Novium is headquartered in St. Augustine, United States.